UK Providing $9.7M for Tumor Profiling and Data Capture R&D Projects | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The UK's Technology Strategy Board announced it is providing about £6 million ($9.7 million) for R&D projects focused on tumor profiling and data capture.

The funds, announced on Thursday, are being given to projects headed by Affymetrix, Aridhia Informatics, IDBS, Life Technologies, Oxford Gene Technology, and Source BioScience.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.